- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRNA
Recent news which mentions MRNA
S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
September 17, 2024
From Benzinga
Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday?
September 17, 2024
From Benzinga
What's Going On With Moderna Shares Tuesday?
September 17, 2024
From Benzinga
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
From Benzinga
Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
September 15, 2024
From Benzinga
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
September 15, 2024
Tickers
MRNA
From Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
From Motley Fool
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
September 14, 2024
Tickers
MRNA
From Motley Fool
Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target
September 13, 2024
From Benzinga
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
September 13, 2024
From Benzinga
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
September 13, 2024
From Benzinga
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day
September 13, 2024
Tickers
MRNA
From Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
From Motley Fool
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
September 13, 2024
From Motley Fool
From Benzinga
Why Are Novavax Shares Trading Lower Today?
September 12, 2024
From Benzinga
Stocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday?
September 12, 2024
From Benzinga
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations
September 12, 2024
From Benzinga
Nasdaq, S&P 500 Set For Modest Gains As Investors Eye August Inflation Data And ECB Rate Decision
September 12, 2024
From Benzinga
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
From Motley Fool
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
September 11, 2024
From Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
From Motley Fool
Wall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday?
September 09, 2024
From Benzinga
Why Is Moderna Stock Trading Higher On Monday?
September 09, 2024
From Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
From Benzinga
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
September 07, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.